NEW YORK (TheStreet) -- Shares of Bristol-Myers Squibb (BMY) - Get Bristol-Myers Squibb Company Report are up 0.23% to $62.21 today ahead of the biopharmaceutical company's fourth-quarter earnings report before the market open tomorrow.

The consensus estimate calls for Bristol-Myers Squibb to report earnings of 41 cents a share on revenue of $4.03 billion. In the fourth quarter last year, the company posted earnings of 51 cents a share, which beat the consensus estimate of 43 cents a share, according to analysts polled by Thomson Reuters. Revenue totaled $4.44 billion, above analysts' estimates of $4.31 billion.

In the third quarter of 2014, Bristol-Myers Squibb posted EPS of 45 cents a share, which beat the consensus estimate of 42 cents a share. Revenue totaled $3.92 billion, which surpassed estimates of $3.8 billion.

Exclusive Report:Jim Cramer's Best Stocks for 2015

TheStreet Recommends

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BMY data by YCharts

Image placeholder title

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.